Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Dupixent Syringe

Dupilumab

Open in the dashboard

Part D claims

131,665

Prescriptions dispensed, refills included

Drug cost

$520,797,864

Paid at the pharmacy, in all

Prescribers

5,937

With 11 or more claims of it

In 2024, Medicare Part D recorded 131,665 claims for Dupixent Syringe (dupilumab) from 5,937 prescribers, at a total drug cost of $520.8 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 53 states and territories
Part D claims for Dupixent Syringe by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 561 13,938 $53,519,272
NY 510 12,943 $51,468,366
FL 354 7,448 $29,209,474
TX 354 7,207 $28,851,111
MA 257 6,415 $25,677,252
PA 271 5,944 $23,279,404
GA 234 5,561 $21,623,371
NC 213 4,441 $17,749,896
NJ 185 4,241 $16,765,293
OH 206 3,978 $15,611,159
MI 154 3,876 $14,985,793
IL 170 3,349 $13,568,328
AZ 126 3,081 $12,853,155
LA 121 3,033 $11,883,144
TN 145 3,025 $11,962,794
The other 38 states and territories
State Prescribers Claims Drug cost
KY 123 2,885 $11,288,063
CT 111 2,785 $11,673,107
VA 146 2,743 $10,913,753
SC 98 2,475 $10,500,424
AL 108 2,402 $9,450,593
IN 115 2,370 $9,216,136
CO 115 2,319 $9,067,538
WA 108 2,072 $8,381,878
WI 98 2,061 $8,052,386
MD 110 2,034 $8,359,387
MO 84 1,787 $7,020,600
MN 86 1,659 $6,377,897
OR 78 1,452 $5,749,595
PR 29 1,219 $4,761,769
OK 61 1,091 $4,330,504
WV 43 1,011 $3,852,399
MS 46 925 $3,576,228
NV 36 868 $3,444,904
AR 42 814 $3,136,959
IA 45 752 $2,913,800
HI 33 746 $2,927,013
ME 33 703 $2,725,023
UT 35 668 $2,788,784
KS 32 568 $2,230,877
NH 23 538 $2,103,785
DE 24 527 $2,136,347
NE 32 523 $2,016,862
RI 30 512 $1,969,316
ID 22 394 $1,632,935
SD 25 389 $1,459,300
VT 20 372 $1,559,253
MT 14 330 $1,272,323
DC 16 293 $1,251,810
NM 19 278 $1,150,884
AK 14 270 $1,184,932
ND 16 264 $982,811
WY 4 62 $231,298
VI 2 24 $98,580

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 34
Part D claims for Dupixent Syringe by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Dermatology 1,924 43,850 $173,620,303
Allergy/ Immunology 1,056 29,432 $117,991,073
Physician Assistant 815 16,799 $66,135,719
Pulmonary Disease 696 14,758 $57,588,165
Nurse Practitioner 607 11,873 $46,545,337
Otolaryngology 236 4,316 $16,822,060
Internal Medicine 236 4,178 $16,120,310
Family Practice 129 1,990 $7,490,813
Critical Care (Intensivists) 75 1,616 $6,204,605
Student in an Organized Health Care Education/Training Program 50 822 $3,171,410
Pediatric Medicine 23 520 $2,081,858
Gastroenterology 28 353 $2,641,434
General Practice 7 269 $1,025,852
Micrographic Dermatologic Surgery 8 150 $598,887
Sleep Medicine 6 83 $314,661

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Huachen Wei Dermatology NY 386 $1,457,957 $270
Ashok Mittal Pulmonary Disease FL 314 $1,189,082 None on record
Gurmit Gill Pulmonary Disease NY 270 $1,004,714 $655
Dmitry Khasak Dermatology NY 265 $973,789 $276
Craig Wiggins Nurse Practitioner AZ 221 $934,291 $369

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for dupilumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record